108 related articles for article (PubMed ID: 16322383)
1. GH treatment reduces trunkal adiposity in HIV-infected patients with lipodystrophy: a randomized placebo-controlled study.
Luzi L; Meneghini E; Oggionni S; Tambussi G; Piceni-Sereni L; Lazzarin A
Eur J Endocrinol; 2005 Dec; 153(6):781-9. PubMed ID: 16322383
[TBL] [Abstract][Full Text] [Related]
2. Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy.
Rietschel P; Hadigan C; Corcoran C; Stanley T; Neubauer G; Gertner J; Grinspoon S
J Clin Endocrinol Metab; 2001 Feb; 86(2):504-10. PubMed ID: 11158000
[TBL] [Abstract][Full Text] [Related]
3. Long-term high-physiological-dose growth hormone reduces intra-abdominal fat in HIV-infected patients with a neutral effect on glucose metabolism.
Hansen BR; Haugaard SB; Jensen FK; Jensen JE; Andresen L; Iversen J; Andersen O
HIV Med; 2010 Apr; 11(4):266-75. PubMed ID: 20002779
[TBL] [Abstract][Full Text] [Related]
4. Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.
Lo J; You SM; Canavan B; Liebau J; Beltrani G; Koutkia P; Hemphill L; Lee H; Grinspoon S
JAMA; 2008 Aug; 300(5):509-19. PubMed ID: 18677023
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial.
Koutkia P; Canavan B; Breu J; Torriani M; Kissko J; Grinspoon S
JAMA; 2004 Jul; 292(2):210-8. PubMed ID: 15249570
[TBL] [Abstract][Full Text] [Related]
6. Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial.
Hadigan C; Corcoran C; Basgoz N; Davis B; Sax P; Grinspoon S
JAMA; 2000 Jul; 284(4):472-7. PubMed ID: 10904511
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection.
Engelson ES; Glesby MJ; Mendez D; Albu JB; Wang J; Heymsfield SB; Kotler DP
J Acquir Immune Defic Syndr; 2002 Aug; 30(4):379-91. PubMed ID: 12138344
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial.
Glesby MJ; Albu J; Chiu YL; Ham K; Engelson E; He Q; Muthukrishnan V; Ginsberg HN; Donovan D; Ernst J; Lesser M; Kotler DP
PLoS One; 2013; 8(4):e61160. PubMed ID: 23593417
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant growth hormone on visceral fat accumulation: pilot study in human immunodeficiency virus-infected adolescents.
Viganò A; Mora S; Manzoni P; Schneider L; Beretta S; Molinaro M; di Natale B; Brambilla P
J Clin Endocrinol Metab; 2005 Jul; 90(7):4075-80. PubMed ID: 15840750
[TBL] [Abstract][Full Text] [Related]
10. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data.
Falutz J; Mamputu JC; Potvin D; Moyle G; Soulban G; Loughrey H; Marsolais C; Turner R; Grinspoon S
J Clin Endocrinol Metab; 2010 Sep; 95(9):4291-304. PubMed ID: 20554713
[TBL] [Abstract][Full Text] [Related]
11. Low-dose growth hormone therapy reduces inflammation in HIV-infected patients: a randomized placebo-controlled study.
Lindboe JB; Langkilde A; Eugen-Olsen J; Hansen BR; Haupt TH; Petersen J; Andersen O
Infect Dis (Lond); 2016; 48(11-12):829-37. PubMed ID: 27417288
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human growth hormone: rationale for use in the treatment of HIV-associated lipodystrophy.
Benedini S; Terruzzi I; Lazzarin A; Luzi L
BioDrugs; 2008; 22(2):101-12. PubMed ID: 18345707
[TBL] [Abstract][Full Text] [Related]
13. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
Lo JC; Mulligan K; Noor MA; Schwarz JM; Halvorsen RA; Grunfeld C; Schambelan M
J Clin Endocrinol Metab; 2001 Aug; 86(8):3480-7. PubMed ID: 11502767
[TBL] [Abstract][Full Text] [Related]
14. GH response to GHRH plus arginine is impaired in lipoatrophic women with human immunodeficiency virus compared with controls.
Zirilli L; Orlando G; Carli F; Madeo B; Cocchi S; Diazzi C; Carani C; Guaraldi G; Rochira V
Eur J Endocrinol; 2012 Mar; 166(3):415-24. PubMed ID: 22189998
[TBL] [Abstract][Full Text] [Related]
15. Effect of Recombinant Human Growth Hormone and Rosiglitazone for HIV-Associated Abdominal Fat Accumulation on Adiponectin and other Markers of Inflammation.
Leung V; Chiu YL; Kotler DP; Albu J; Zhu YS; Ham K; Engelson ES; Hammad H; Christos P; Donovan DS; Ginsberg HN; Glesby MJ
HIV Clin Trials; 2016 Mar; 17(2):55-62. PubMed ID: 27077672
[TBL] [Abstract][Full Text] [Related]
16. Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial.
Bredella MA; Lin E; Brick DJ; Gerweck AV; Harrington LM; Torriani M; Thomas BJ; Schoenfeld DA; Breggia A; Rosen CJ; Hemphill LC; Wu Z; Rifai N; Utz AL; Miller KK
Eur J Endocrinol; 2012 Apr; 166(4):601-11. PubMed ID: 22275471
[TBL] [Abstract][Full Text] [Related]
17. Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency.
Filipsson Nyström H; Barbosa EJ; Nilsson AG; Norrman LL; Ragnarsson O; Johannsson G
J Clin Endocrinol Metab; 2012 Sep; 97(9):3185-95. PubMed ID: 22791760
[TBL] [Abstract][Full Text] [Related]
18. A randomized, open-label study to compare the effects of two different doses of recombinant human growth hormone on fat reduction and fasting metabolic parameters in HIV-1-infected patients with lipodystrophy.
Bickel M; Zangos S; Jacobi V; Lutz T; Knecht G; Goebel F; Staszewski S; Klauke S
HIV Med; 2006 Sep; 7(6):397-403. PubMed ID: 16903985
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone deficiency and human immunodeficiency virus.
Rochira V; Guaraldi G
Best Pract Res Clin Endocrinol Metab; 2017 Feb; 31(1):91-111. PubMed ID: 28477736
[TBL] [Abstract][Full Text] [Related]
20. Comparison of body composition assessment methods in patients with human immunodeficiency virus-associated wasting receiving growth hormone.
Esposito JG; Thomas SG; Kingdon L; Ezzat S
J Clin Endocrinol Metab; 2006 Aug; 91(8):2952-9. PubMed ID: 16757527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
